Get access to Glenmark information and resources for stories in development.
Find recent and archived press releases.
Glenmark Pharmaceuticals Announces Pre-Clinical Data Results for Experimental GBR 1302-BEAT Technology
November 4, 2016
October 25, 2016
August 8, 2016
Search Result :-Is an investigational new drug that has not been approved for commercial distribution in the United States.
US Media Contact
For media inquiries only, please contact An Phan, Corporate Communications. An.Phan@glenmarkpharma.com
For more information on Glenmark Pharmaceuticals Ltd., including Annual Reports, Analyst Presentations and Financial Results, please visit our Investor Relations.